Latest Articlesddd
Can-Fite Biopharma Good News We learned, from Petach Tikva, Israel, that Can-Fite Biopharma (CANF) – a …
TCR2 Therapeutics TCR2 Therapeutics (TCRR) is a clinical-stage cell therapy company developing a pipeline of novel T …
The most important news in biological sciences is the high degree of success the biological revolution …
Cassava Sciences Released a Statement Cassava Sciences, Inc. (SAVA) – a biotechnology company focused on Alzheimer’s …
Agenus Good News for Balstilimab Monotherapy Agenus (AGEN) announced that results from a global Phase 2 …
Cassava Sciences Responds to Misleading Posts Cassava Sciences (SAVA) today issued a response to claims that …
Cara Therapeutics and Vifor Pharma Granted US FDA Approval of KORSUVA™ Indeed, the U.S. Food and …
Axsome Therapeutics Inc and Major Depressive Disorder In a teleconference on August 20, 2021, the U.S. …
Sutro Biopharma Inc Granted Fast Track Designation for STRO-002 by the US FDA Sutro Biopharma Inc …
Virpax Pharmaceuticals Virpax Pharmaceuticals (VRPX) - a company specializing in developing product candidates for pain management, CNS …
BeiGene Ltd and EUSA Pharma Receive Approval from China NMPA for QARZIBA® BeiGene Ltd (BGNE) and EUSA …
Travere Therapeutics Sparsentan for IgAN Positive Results Phase 3 PROTECT Study of Travere Therapeutics (TVTX) product sparsentan …
Akero Therapeutics Inc Akero Therapeutics Inc (AKRO) is a clinical-stage cardio-metabolic company developing transformational treatments for …
Vir Biotechnology: What We've Learned from Dr. George Scangos George Scangos, PhD. is the chief executive …
Reata Pharmaceuticals Two Stories Omaveloxolone in Patients with Friedreich’s Ataxia Several communications between Reata Pharmaceuticals (RETA) …
Agenus Inc News and Q2 Results for 201 Agenus (AGEN) announced results with better than usual …
Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …
Exelixis sNDA Accepted by the US FDA for CABOMETYX® The U.S. Food and Drug Administration (FDA) …
Novartis Partial Clinical Trial Hold for OAV-101 IT for SMA Lifted Novartis (NVS) announced that the …
Sanofi Will Acquire Translate Bio Sanofi (SNY) will acquire all the outstanding shares of Translate Bio (
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
